Carna Biosciences, Inc.

TSE:4572.T

407 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income -1,152.895-1,323.399-532.499-1,102.487913.059-1,206.799-733.38-288.926486.09-844.836-279.003-447.964-355.175-394.763-313.053-502.035
Depreciation & Amortization 35.61233.80819.16412.419.39412.71612.11421.80119.21967.5237.5938.9337.41561.808102.53252.553
Deferred Income Tax -733.557044.579-112.4430.58800000000000
Stock Based Compensation 40.24249.74653.67457.5241.90800000000000
Change In Working Capital -593.068524.384-1,127.585-90.888421.06618.664100.14253.946-137.81585.563-15.518-25.156-3.751-1.322-236.44446.509
Accounts Receivables -599.721,069.478-1,110.099-13.951-29.1373.77829.53168.459-96.02828-28-100000
Inventory -21.609-8.044-5.966-5.10711.3667.1863.9254.059-6.0950.315-1.762-9.30514.687-17.329-34.127-23.068
Accounts Payables -0.762-0.3310.776-1.6552.694-2.534-0.482-11.90411.1790000000
Other Working Capital 29.023-536.719-12.296-70.175436.14311.47896.21749.887-131.7285.248-13.756-15.851-18.43816.007-202.31769.577
Other Non Cash Items 726.2027.0716.055-25.08761.75847.39360.069-239.78834.151222.7779.8979.007-28.94224.32727.362135.3
Operating Cash Flow -1,677.464-708.39-1,536.612-1,260.9721,477.773-1,128.026-561.055-452.967401.645-468.976-247.034-425.183-350.453-309.95-419.603-267.673
Investing Activities:
Investments In Property Plant And Equipment -11.53-126.001-41.677-68.854-42.036-58.314-38.13-31.07-3-41.85-7.642-37.907-11.52-31.52-22.136-202.51
Acquisitions Net 00001.091000000000-8.160
Purchases Of Investments 0000000000-0.93300-9.995-2000
Sales Maturities Of Investments 0000000281.87600000.8150201.0740
Other Investing Activites 0.1540.3050-1.57910-0.001-2.80200.024-0.001-0.0013.538-3.739113.086-111.364
Investing Cash Flow -11.376-125.696-41.677-70.433-40.945-58.314-38.131248.004-3-41.826-8.576-37.908-7.167-45.25483.864-313.874
Financing Activities:
Debt Repayment -152.02-239.525-189.925-299-257.841-287.578-173.628-115.898-47.259-79.658-43.606-69.216-63.504-41.142-1.998-25
Common Stock Issued 1,343.338600.824949.271,023.4232,071.741625.128361.611273.412543.93246.232642.603283.52100314.822874.691
Common Stock Repurchased 0000000000000000
Dividends Paid 0000000000000000
Other Financing Activities -9.2915.707305.642724307.848349.972107.831597.383106.265100102.12727808080-36.589
Financing Cash Flow 1,182.027367.0061,064.987724.4232,121.748687.522295.814754.897602.93866.574701.124241.30516.49638.858392.824813.102
Other Information:
Effect Of Forex Changes On Cash 16.86528.29331.994-8.9311.224-2.144-1.595-13.689-3.3853.410.0622.144-0.416-1.1931.498-0.451
Net Change In Cash -489.947-438.786-481.308-615.9143,559.802-500.964-304.968536.245998.199-440.828455.577-219.641-341.542-317.5458.584231.103
Cash At End Of Period 2,889.1013,379.0483,817.8344,299.1424,915.0561,355.2541,856.2182,161.1861,624.941626.7421,067.57611.993831.6341,173.1761,490.7161,432.132